IWP
HRTX icon

IAG Wealth Partners’s Heron Therapeutics HRTX Stock Holding History

IAG Wealth Partners’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-250
Closed -$5K – 377
2021
Q1 		$5K Hold
250
– – ﹤0.01% 310
2020
Q4 		$6K Hold
250
– – ﹤0.01% 290
2020
Q3 		$4K Hold
250
– – ﹤0.01% 294
2020
Q2 		$4K Buy
+250
New +$4.11K ﹤0.01% 297

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IAG Wealth Partners's HRTX Position: Q2 2021 in Review

IAG Wealth Partners sold out of Heron Therapeutics (HRTX) in Q2 2021, closing a stake of 250 shares — an estimated $5K sold.

IAG Wealth Partners first reported a position in HRTX in Q2 2020 and held it in 4 quarters. The position peaked at $6K in Q4 2020. 189 funds tracked by Wall St. Rank hold HRTX as of Q2 2021.

  • IAG Wealth Partners reported no remaining Heron Therapeutics position as of Q2 2021 after selling out during the quarter.
  • IAG Wealth Partners sold 250 Heron Therapeutics shares in Q2 2021, an estimated $5K.
  • IAG Wealth Partners first reported a position in Heron Therapeutics in Q2 2020 and held it in 4 quarters.
  • IAG Wealth Partners's Heron Therapeutics position peaked at $6K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2021.

Based on IAG Wealth Partners's 13F filing for Q2 2021, filed 4 Aug 2021.